These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 30371181)
1. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis. Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181 [TBL] [Abstract][Full Text] [Related]
2. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Moranville MP; Choi S; Hogg J; Anderson AS; Rich JD Cardiovasc Ther; 2015 Apr; 33(2):42-9. PubMed ID: 25712736 [TBL] [Abstract][Full Text] [Related]
3. Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum: The CLOROTIC Trial. Sánchez-Marteles M; Garcés-Horna V; Morales-Rull JL; Casado J; Carrera-Izquierdo M; Conde-Martel A; Dávila-Ramos MF; Llácer P; Salamanca-Bautista P; Ruiz R; Aramburu-Bodas O; Formiga F; Manzano L; Trullàs JC JACC Heart Fail; 2024 Oct; 12(10):1719-1730. PubMed ID: 38934966 [TBL] [Abstract][Full Text] [Related]
4. Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics. Nakamura M; Sunagawa O; Kinugawa K Int Heart J; 2018; 59(1):87-93. PubMed ID: 29375117 [TBL] [Abstract][Full Text] [Related]
5. Metolazone Versus Chlorothiazide in Acute Heart Failure Patients With Diuretic Resistance and Renal Dysfunction: A Retrospective Cohort Study. Gibson CM; Beard MM; Escano AK; Good BL; Potter TG; Truong AM; Van Tassell B J Cardiovasc Pharmacol; 2024 Oct; 84(4):451-456. PubMed ID: 39115872 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance. Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709 [TBL] [Abstract][Full Text] [Related]
7. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial. Cox ZL; Hung R; Lenihan DJ; Testani JM JACC Heart Fail; 2020 Mar; 8(3):157-168. PubMed ID: 31838029 [TBL] [Abstract][Full Text] [Related]
8. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631 [TBL] [Abstract][Full Text] [Related]
12. A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure. Steuber TD; Janzen KM; Howard ML Pharmacotherapy; 2020 Sep; 40(9):924-935. PubMed ID: 32639593 [TBL] [Abstract][Full Text] [Related]
13. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. Yeoh SE; Osmanska J; Petrie MC; Brooksbank KJM; Clark AL; Docherty KF; Foley PWX; Guha K; Halliday CA; Jhund PS; Kalra PR; McKinley G; Lang NN; Lee MMY; McConnachie A; McDermott JJ; Platz E; Sartipy P; Seed A; Stanley B; Weir RAP; Welsh P; McMurray JJV; Campbell RT Eur Heart J; 2023 Aug; 44(31):2966-2977. PubMed ID: 37210742 [TBL] [Abstract][Full Text] [Related]
14. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947 [TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis. Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731 [TBL] [Abstract][Full Text] [Related]
16. Combination of loop diuretics with thiazide-type diuretics in heart failure. Jentzer JC; DeWald TA; Hernandez AF J Am Coll Cardiol; 2010 Nov; 56(19):1527-34. PubMed ID: 21029871 [TBL] [Abstract][Full Text] [Related]
17. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]